Gene amplification in human cancer cells generates two cytogenetically identifiable structures: extrachromosomal double minutes (DMs) and the chromosomal homogeneously staining region (HSR). DMs are composed of autonomously replicating circular DNA of genomic origin, and they tell us about how the extrachromosomal elements may behave in the cells, how they were entrapped by the micronuclei and how they were eliminated from the cells. On the other hand, the episome model predicts that extrachromosomal elements excised from the chromosome arm might generate DMs, and the breakage-fusion-bridge (BFB) cycle model explains the generation of the HSR. In accordance with this, a plasmid bearing a mammalian replication initiation region (IR) and a matrix attachment region (MAR) mimics gene amplification and generates DMs and HSRs de novo. The IR/MAR gene amplification system extends our understanding on the mechanism of gene amplification and the behavior of amplified genes. Furthermore, the system may suggest the way how extrachromosomal elements in general may alter the chromosome architecture and function.

Keywords:
Double minutes, Gene amplification, Homogeneously staining region, Matrix attachment region, Replication initiation region
1.
Adachi Y, Kas E, Laemmli UK: Preferential, cooperative binding of DNA topoisomerase II to scaffold-associated regions. EMBO J 8:3997–4006 (1989).
2.
Aladjem MI, Fanning E: The replicon revisited: An old model learns new tricks in metazoan chromosomes. EMBO Rep 5:686–691 (2004).
3.
Albertson DG: Gene amplification in cancer. Trends Genet 22:447–455 (2006).
4.
Albertson DG, Collins C, McCormick F, Gray JW: Chromosome aberrations in solid tumors. Nat Genet 34:369–376 (2003).
5.
Ambros IM, Rumpler S, Luegmayr A, Hattinger CM, Strehl S, et al: Neuroblastoma cells can actively eliminate supernumerary mycn gene copies by micronucleus formation – sign of tumour cell revertance? Eur J Cancer [a] 33A:2043–2049 (1997).
6.
Anachkova B, Djeliova V, Russev G: Nuclear matrix support of DNA replication. J Cell Biochem 96:951–961 (2005).
7.
Anker P, Stroun M, Maurice PA: Spontaneous release of DNA by human blood lymphoctyes as shown in an in vitro system. Cancer Res 35:2375–2382 (1975).
8.
Baiker A, Maercker C, Piechaczek C, Schmidt SB, Bode J, et al: Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix. Nat Cell Biol 2:182–184 (2000).
9.
Bailey SM, Murnane JP: Telomeres, chromosome instability and cancer. Nucleic Acids Res 34:2408–2417 (2006).
10.
Ballestas ME, Chatis PA, Kaye KM: Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641–644 (1999).
11.
Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Joukov V, Walter JC, et al: The nucleosomal surface as a docking station for Kaposi’s sarcoma herpesvirus lana. Science 311:856–861 (2006).
12.
Benner SE, Wahl GM, Von Hoff DD: Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines. Anti-Cancer Drugs 2:11–25 (1991).
13.
Berrios M, Osheroff N, Fisher PA: In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction. Proc Natl Acad Sci USA 82:4142–4146 (1985).
14.
Biamontim G, Paixao S, Montecucco A, Peverali FA, Riva S, Falaschi A: Is DNA sequence sufficient to specify DNA replication origins in metazoan cells? Chromosome Res 11:403–412 (2003).
15.
Bosisio D, Marazzi I, Agresti A, Shimizu N, Bianchi ME, Natoli G: A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. EMBO J 25:798–810 (2006).
16.
Botchan M: Hitchhiking without covalent integration. Cell 117:280–281 (2004).
17.
Calos MP: Stability without a centromere. Proc Natl Acad Sci USA 95:4084–4085 (1998).
18.
Canute GW, Longo SL, Longo JA, Winfield JA, Nevaldine BH, Hahn PJ: Hydroxyurea accelerates the loss of epidermal growth factor receptor genes amplified as double-minute chromosomes in human glioblastoma multiforme. Neurosurgery 39:976–983 (1996).
19.
Canute GW, Longo SL, Longo JA, Shetler MM, Coyle TE, et al: The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme. Neurosurgery 42:609–616 (1998).
20.
Carroll SM, Gaudray P, De RM, Emery JF, Meinkoth JL, et al: Characterization of an episome produced in hamster cells that amplify a transfected CAD gene at high frequency: functional evidence for a mammalian replication origin. Mol Cell Biol 7:1740–1750 (1987).
21.
Carroll SM, DeRose ML, Gaudray P, Moore CM, Needham V, et al: Double minute chromosomes can be produced from precursors derived from a chromosomal deletion. Mol Cell Biol 8:1525–1533 (1988).
22.
Chen S, Bigner SH, Modrich P: High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6. Proc Natl Acad Sci USA 98:13802–13807 (2001).
23.
Ciullo M, Debily MA, Rozier L, Autiero M, Billault A, et al: Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: The model of PIP gene duplication from a break at FRA7I. Hum Mol Genet 11:2887–2894 (2002).
24.
Claycomb JM, Orr-Weaver TL: Developmental gene amplification: insights into DNA replication and gene expression. Trends Genet 21:149–162 (2005).
25.
Cockerill PN, Garrard WT: Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44:273–282 (1986).
26.
Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M: Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215–225 (1997).
27.
Crott JW, Mashiyama ST, Ames BN, Fenech MF: Methylene tetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitro. Carcinogenesis 22:1019–1025 (2001).
28.
Debatisse M, Malfoy B: Gene amplification mechanisms, in Nigg EA (ed): Genome Instability in Cancer Development. Adv Exp Med Biol, vol 570, pp 570:343–361 (2005).
29.
Difilippantonio MJ, Petersen S, Chen HT, Johnson R, Jasin M, et al: Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J Exp Med 196:469–480 (2002).
30.
Dyer KA, Canfield TK, Gartler SM: Molecular cytological differentiation of active from inactive X domains in interphase: implications for X chromosome inactivation. Cytogenet Cell Genet 50:116–120 (1989).
31.
Earnshaw WC, Halligan B, Cooke CA, Heck MM, Liu LF: Topoisomerase II is a structural component of mitotic chromosome scaffolds. J Cell Biol 100:1706–1715 (1985).
32.
Eckhardt SG, Dai A, Davidson KK, Forseth BJ, Wahl GM, Von Hoff DD: Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-MYC. Proc Natl Acad Sci USA 91:6674–6678 (1994).
33.
El-Hizawi S, Lagowski JP, Kulesz-Martin M, Albor A: Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins. Cancer Res 62:3264–3270 (2002).
34.
Fenech M: Cytokinesis-block micronucleus cytome assay. Nat Protocols 2:1084–1104 (2007).
35.
Gaubatz JW: Extrachromosomal circular DNAs and genomic sequence plasticity in eukaryotic cells. Mutat Res 237:271–292 (1990).
36.
Gilbert DM: Making sense of eukaryotic DNA replication origins. Science 294:96–100 (2001).
37.
Gisselsson D, Pettersson L, Hoglund M, Heidenblad M, Gorunova L, et al: Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 97:5357–5362 (2000).
38.
Haaf T, Schmid M: Analysis of double minutes and double minute-like chromatin in human and murine tumor cells using antikinetochore antibodies. Cancer Genet Cytogenet 30:73–82 (1988).
39.
Haaf T, Raderschall E, Reddy G, Ward DC, Radding CM, Golub EI: Sequestration of mammalian rad51-recombination protein into micronuclei. J Cell Biol 144:11–20 (1999).
40.
Haber JE, Debatisse M: Gene amplification: Yeast takes a turn. Cell 125:1237–1240 (2006).
41.
Hamkalo BA, Farnham PJ, Johnston R, Schimke RT: Ultrastructural features of minute chromosomes in a methotrexate-resistant mouse 3T3 cell line. Proc Natl Acad Sci USA 82:1026–1030 (1985).
42.
Hando JC, Tucker JD, Davenport M, Tepperberg J, Nath J: X chromosome inactivation and micronuclei in normal and Turner individuals. Hum Genet 100:624–628 (1997).
43.
Hashizume T, Shimizu N: Dissection of mammalian replicators by a novel plasmid stability assay. J Cell Biochem 101:552–565 (2007).
44.
Hoffelder DR, Luo L, Burke NA, Watkins SC, Gollin SM, Saunders WS: Resolution of anaphase bridges in cancer cells. Chromosoma 112:389–397 (2004).
45.
Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, et al: Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62:6240–6245 (2002).
46.
Itoh N, Shimizu N: DNA replication-dependent intranuclear relocation of double minute chromatin. J Cell Sci 111:3275–3285 (1998).
47.
Jenke AC, Stehle IM, Herrmann F, Eisenberger T, Baiker A, et al: Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. Proc Natl Acad Sci USA 101:11322–11327 (2004).
48.
Kanda T, Wahl GM: The dynamics of acentric chromosomes in cancer cells revealed by GFP-based chromosome labeling strategies. J Cell Biochem Suppl:107–114 (2000).
49.
Kanda T, Otter M, Wahl GM: Mitotic segregation of viral and cellular acentric extrachromosomal molecules by chromosome tethering. J Cell Sci 114:49–58 (2001).
50.
Kapoor P, Lavoie BD, Frappier L: EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases. Mol Cell Biol 25:4934–4945 (2005).
51.
Kaufman RJ, Brown PC, Schimke RT: Loss and stabilization of amplified dihydrofolate reductase genes in mouse sarcoma s-180 cell lines. Mol Cell Biol 1:1084–1093 (1981).
52.
Kaufman RJ, Sharp PA, Latt SA: Evolution of chromosomal regions containing transfected and amplified dihydrofolate reductase sequences. Mol Cell Biol 3:699–711 (1983).
53.
Kimura M, Umegaki K, Higuchi M, Thomas P, Fenech M: Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J Nutr 134:48–56 (2004).
54.
Lee JS, Kamijo K, Ohara N, Kitamura T, Miki T: MgcRacGAP regulates cortical activity through Rhoa during cytokinesis. Exp Cell Res 293:275–282 (2004).
55.
Lehman CW, Botchan MR: Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation. Proc Natl Acad Sci USA 95:4338–4343 (1998).
56.
Levan A, Levan G: Have double minutes functioning centromeres? Hereditas 88:81–92 (1978).
57.
Lin CT, Lyu YL, Xiao H, Lin WH, Whang-Peng J: Suppression of gene amplification and chromosomal DNA integration by the DNA mismatch repair system. Nucleic Acids Res 29:3304–3310 (2001).
58.
Lin Y, Waldman AS: Capture of DNA sequences at double-strand breaks in mammalian chromosomes. Genetics 158:1665–1674 (2001).
59.
Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923–935 (1992).
60.
Lo AW, Sabatier L, Fouladi B, Pottier G, Ricoul M, Murnane JP: DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line. Neoplasia 4:531–538 (2002).
61.
Lobachev KS, Rattray A, Narayanan V: Hairpin- and cruciform-mediated chromosome breakage: Causes and consequences in eukaryotic cells. Front Biosci 12:4208–4220 (2007).
62.
Lu J, Gilbert DM: Proliferation-dependent and cell cycle regulated transcription of mouse pericentric heterochromatin. J Cell Biol 179:411–421 (2007).
63.
Ma C, Martin S, Trask B, Hamlin JL: Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. Genes Dev 7:605–620 (1993).
64.
Marechal V, Dehee A, Chikhi-Brachet R, Piolot T, Coppey-Moisan M, Nicolas JC: Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol 73:4385–4392 (1999).
65.
McClintock B: Chromosome organization and genic expression. Cold Spring Harbor Symp Quant Biol 16:13–47 (1951).
66.
Mondello C, Rebuzzini P, Dolzan M, Edmonson S, Taccioli GE, Giulotto E: Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit. Cancer Res 61:4520–4525 (2001).
67.
Murnane JP: Telomeres and chromosome instability. DNA Repair 5:1082–1092 (2006).
68.
Murnane JP, Sabatier L: Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays 26:1164–1174 (2004).
69.
Myllykangas S, Knuutila S: Manifestation, mechanisms and mysteries of gene amplifications. Cancer Lett 232:79–89 (2006).
70.
Narayanan V, Mieczkowski PA, Kim HM, Petes TD, Lobachev KS: The pattern of gene amplification is determined by the chromosomal location of hairpin-capped breaks. Cell 125:1283–1296 (2006).
71.
Nevaldine BH, Rizwana R, Hahn PJ: Differential sensitivity of double minute chromosomes to hydroxyurea treatment in cultured methotrexate-resistant mouse cells. Mut Res 406:55–62 (1999).
72.
Nito S, Ariyuki F, Okaniwa A: Spontaneous expulsion of micronuclei by enucleation in the micronucleus assay. Mut Res 207:185–192 (1988).
73.
Omasa T: Gene amplification and its application in cell and tissue engineering. J Biosci Bioeng 94:600–605 (2002).
74.
Parton JW, Garriott ML, Beyers JE: Expulsion of demecolcine-induced micronuclei from mouse bone marrow polychromatic erythrocytes. Environ Mol Mutagen 17:79–83 (1991).
75.
Paulin-Levasseur M, Blake DL, Julien M, Rouleau L: The MAN antigens are non-lamin constituents of the nuclear lamina in vertebrate cells. Chromosoma 104:367–379 (1996).
76.
Paulson TG, Almasan A, Brody LL, Wahl GM: Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol Cell Biol 18:3089–3100 (1998).
77.
Piechaczek C, Fetzer C, Baiker A, Bode J, Lipps HJ: A vector based on the SV40 origin of replication and chromosomal S/MARS replicates episomally in CHO cells. Nucleic Acids Res 27:426–428 (1999).
78.
Pipiras E, Coquelle A, Bieth A, Debatisse M: Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J 17:325–333 (1998).
79.
Pouyssegur J, Dayan F, Mazure NM: Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 441:437–443 (2006).
80.
Price GB, Allarakhia M, Cossons N, Nielsen T, Diaz-Perez M, et al: Identification of a cis-element that determines autonomous DNA replication in eukaryotic cells. J Biol Chem 278:19649–19659 (2003).
81.
Rattner JB, Lin CC: Ultrastructural organization of double minute chromosomes and HSR regions in human colon carcinoma cells. Cytogenet Cell Genet 38:176–181 (1984).
82.
Raymond E, Faivre S, Weiss G, McGill J, Davidson K, et al: Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomas. Clin Cancer Res 7:1171–1180 (2001).
83.
Rothstein R, Michel B, Gangloff S: Replication fork pausing and recombination or ‘Gimme 4a break’. Genes Dev 14:1–10 (2000).
84.
Sanchez AM, Barrett JT, Schoenlein PV: Fractionated ionizing radiation accelerates loss of amplified MDR1 genes harbored by extrachromosomal DNA in tumor cells. Cancer Res 58:3845–3854 (1998).
85.
Schaarschmidt D, Baltin J, Stehle IM, Lipps HJ, Knippers R: An episomal mammalian replicon: Sequence-independent binding of the origin recognition complex. EMBO J 23:191–201 (2004).
86.
Schoenlein PV, Barrett JT, Kulharya A, Dohn MR, Sanchez A, et al: Radiation therapy depletes extrachromosomally amplified drug resistance genes and oncogenes from tumor cells via micronuclear capture of episomes and double minute chromosomes. Int J Radiat Oncol Biol Phys 55:1051–1065 (2003).
87.
Schriever SG, Kliesch U, Adler ID: Extruded micronuclei induced by colchicine or acrylamide contain mostly lagging chromosomes identified in paintbrush smears by minor and major mouse DNA probes. Mutagenesis 12:201–207 (1997).
88.
Shima H, Nakayasu M, Aonuma S, Sugimura T, Nagao M: Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide. Proc Natl Acad Sci USA 86:7442–7445 (1989).
89.
Shimizu N, Shingaki K: Macroscopic folding and replication of the homogeneously staining region in late S phase leads to the appearance of replication bands in mitotic chromosomes. J Cell Sci 117:5303–5312 (2004).
90.
Shimizu N, Nakamura H, Kadota T, Kitajima K, Oda T, et al: Loss of amplified c-MYC genes in the spontaneously differentiated HL-60 cells. Cancer Res 54:3561–3567 (1994).
91.
Shimizu N, Kanda T, Wahl GM: Selective capture of acentric fragments by micronuclei provides a rapid method for purifying extrachromosomally amplified DNA. Nat Genet 12:65–71 (1996).
92.
Shimizu N, Itoh N, Utiyama H, Wahl G: Selective entrapment of extrachromosomally amplified DNA by nuclear budding and micronucleation during S-phase. J Cell Biol 140:1307–1320 (1998).
93.
Shimizu N, Shimura T, Tanaka T: Selective elimination of acentric double minutes from cancer cells through the extrusion of micronuclei. Mut Res 448:81–90 (2000).
94.
Shimizu N, Miura Y, Sakamoto Y, Tsutsui K: Plasmids with a mammalian replication origin and a matrix attachment region initiate the event similar to gene amplification. Cancer Res 61:6987–6990 (2001a).
95.
Shimizu N, Ochi T, Itonaga K: Replication timing of amplified genetic regions relates to intranuclear localization but not to genetic activity or G/R band. Exp Cell Res 268:201–210 (2001b).
96.
Shimizu N, Hashizume T, Shingaki K, Kawamoto JK: Amplification of plasmids containing a mammalian replication initiation region is mediated by controllable conflict between replication and transcription. Cancer Res 63:5281–5290 (2003).
97.
Shimizu N, Kamezaki F, Shigematsu S: Tracking of microinjected DNA in live cells reveals the intracellular behavior and elimination of extrachromosomal genetic material. Nucleic Acids Res 33:6296–6307 (2005a).
98.
Shimizu N, Shingaki K, Kaneko-Sasaguri Y, Hashizume T, Kanda T: When, where and how the bridge breaks: Anaphase bridge breakage plays a crucial role in gene amplification and HSR generation. Exp Cell Res 302:233–243 (2005b).
99.
Shimizu N, Hanada N, Utani K, Sekiguchi N: Interconversion of intra- and extra-chromosomal sites of gene amplification by modulation of gene expression and DNA methylation. J Cell Biochem 102:515–529 (2007a).
100.
Shimizu N, Misaka N, Utani K: Nonselective DNA damage induced by a replication inhibitor results in the selective elimination of extrachromosomal double minutes from human cancer cells. Genes Chrom Cancer 46:865–874 (2007b).
101.
Shimura M, Onozuka Y, Yamaguchi T, Hatake K, Takaku F, Ishizaka Y: Micronuclei formation with chromosome breaks and gene amplification caused by VPR, an accessory gene of human immunodeficiency virus. Cancer Res 59:2259–2264 (1999).
102.
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, et al: Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712 (1989).
103.
Smith KA, Gorman PA, Stark MB, Groves RP, Stark GR: Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell 63:1219–1227 (1990).
104.
Smith KA, Stark MB, Gorman PA, Stark GR: Fusions near telomeres occur very early in the amplification of AD genes in Syrian hamster cells. Proc Natl Acad Sci USA 89:5427–5431 (1992).
105.
Snapka RM: Gene amplification as a target for cancer chemotherapy. Oncol Res 4:145–150 (1992).
106.
Snapka RM, Varshavsky A: Loss of unstably amplified dihydrofolate reductase genes from mouse cells is greatly accelerated by hydroxyurea. Proc Natl Acad Sci USA 80:7533–7537 (1983).
107.
Stewart DJ, Tomiak EM, Goss G, Gertler SZ, Logan D, et al: Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer. Lung Cancer 15:115–123 (1996).
108.
Svetlova EY, Razin SV, Debatisse M: Mammalian recombination hot spot in a DNA loop anchorage region: A model for the study of common fragile sites. J Cell Biochem Suppl Suppl 36:170–178 (2001).
109.
Takashina T, Nakayama M: Revival of apoptotic cells that display early-stage dynamic membrane blebbing. FEBS letters 581:4479–4484 (2007).
110.
Tanaka T, Shimizu N: Induced detachment of acentric chromatin from mitotic chromosomes leads to their cytoplasmic localization at G1 and the micronucleation by lamin reorganization at S phase. J Cell Sci 113:697–707 (2000).
111.
Toledo F, Le RD, Buttin G, Debatisse M: Co-amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification. EMBO J 11:2665–2673 (1992).
112.
Trask BJ, Hamlin JL: Early dihydrofolate reductase gene amplification events in CHO cells usually occur on the same chromosome arm as the original locus. Genes Dev 3:1913–1925 (1989).
113.
Tsujii R, Miyoshi K, Tsuno A, Matsui Y, Toh-e A, et al: Ebp2p, yeast homologue of a human protein that interacts with Epstein-Barr virus nuclear antigen 1, is required for pre-rRNA processing and ribosomal subunit assembly. Genes Cells 5:543–553 (2000).
114.
Tsutsui K, Okada S, Watarai S, Seki S, Yasuda T, Shohmori T: Identification and characterization of a nuclear scaffold protein that binds the matrix attachment region DNA. J Biol Chem 268:12886–12894 (1993).
115.
Tucker JD, Nath J, Hando JC: Activation status of the X chromosome in human micronucleated lymphocytes. Hum Genet 97:471–475 (1996).
116.
Utani K, Kawamoto JK, Shimizu N: Micronuclei bearing acentric extrachromosomal chromatin are transcriptionally competent and may perturb the cancer cell phenotype. Mol Cancer Res 5:695–704 (2007).
117.
Valent A, Benard J, Clausse B, Barrois M, Valteau-Couanet D, et al: In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei. Am J Pathol 158:1579–1584 (2001).
118.
Van den Berg C, Von Hoff DD: Use of hydroxyurea to alter drug resistance of human tumor cells. Cancer Treat Res 78:95–114 (1995).
119.
VanDevanter DR, Piaskowski VD, Casper JT, Douglass EC, Von HD: Ability of circular extrachromosomal DNA molecules to carry amplified mycn proto-oncogenes in human neuroblastomas in vivo. J Natl Cancer Inst 82:1815–1821 (1990).
120.
Van Hooser AA, Yuh P, Heald R: The perichromosomal layer. Chromosoma 114:377–388 (2005).
121.
Vasiljeva L, Kim M, Terzi N, Soares LM, Buratowski S: Transcription termination and RNA degradation contribute to silencing of RNA polymerase II transcription within heterochromatin. Mol Cell 29:313–323 (2008).
122.
Vlassov VV, Laktionov PP, Rykova EY: Extracellular nucleic acids. Bioessays 29:654–667 (2007).
123.
Von Hoff D, Forseth B, Bradley T, Wahl G: Hydroxyurea can decrease oncogene copy number in human tumor cell lines. Proc Am Soc Clin Oncol 9:55 (1990).
124.
Von Hoff DD, McGill JR, Forseth BJ, Davidson KK, Bradley TP, et al: Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proc Natl Acad Sci USA 89:8165–8169 (1992).
125.
Wahl GM: The importance of circular DNA in mammalian gene amplification. Cancer Res 49:1333–1340 (1989).
126.
Wahl GM, Padgett RA, Stark GR: Gene amplification causes overproduction of the first three enzymes of UMP synthesis in n-(phosphonacetyl)-l-aspartate-resistant hamster cells. J Biol Chem 254:8679–8689 (1979).
127.
Wahl GM, Robert de Saint Vincent B, DeRose ML: Effect of chromosomal position on amplification of transfected genes in animal cells. Nature 307:516–520 (1984).
128.
Wani MA, Snapka RM: Drug-induced loss of unstably amplified genes. Cancer Invest 8:587–593 (1990).
129.
Wani MA, Strayer JM, Snapka RM: Hypersensitivity to low level cytotoxic stress in mouse cells with high levels of DHFR gene amplification. Anticancer Drugs 1:67–75 (1990).
130.
Willingale-Theune J, Schweiger M, Hirsch-Kauffmann M, Meek AE, Paulin-Levasseur M, Traub P: ultrastructure of Fanconi anemia fibroblasts. J Cell Sci 93:651–665 (1989).
131.
Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937–948 (1992).
132.
You J, Schweiger MR, Howley PM: Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells. J Virol 79:14956–14961 (2005).
133.
Zaharopoulos P, Wong J, Wen JW: Nuclear protrusions in cells from cytologic specimens. Mechanisms of formation. Acta Cytol 42:317–329 (1998).
134.
Zhu C, Mills KD, Ferguson DO, Lee C, Manis J, et al: Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109:811–821 (2002).
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.